Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:I-414-I-419
doi: 10.1161/CIRCULATIONAHA.105.000661
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hillis, G. S.
Right arrow Articles by Oh, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hillis, G. S.
Right arrow Articles by Oh, J. K.
Related Collections
Right arrow CV surgery: coronary artery disease
Right arrow Chronic ischemic heart disease

(Circulation. 2006;114:I-414 – I-419.)
© 2006 American Heart Association, Inc.


Surgery for Coronary Artery Disease

Outcome of Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting

Renal Function and Mortality After 3.8 Years

Graham S. Hillis, MBChB, PhD; Kenton J. Zehr, MD; Amy W. Williams, MD; Hartzell V. Schaff, MD; Thomas A. Orzulak, MD; Richard C. Daly, MD; Charles J. Mullany, MD; Richard J. Rodeheffer, MD; Jae K. Oh, MD

From the Divisions of Cardiovascular Disease (G.S.H., R.J.R, J.K.O.), Nephrology (A.W.W) and Cardiovascular Surgery (K.J.Z., H.V.S., T.A.O., R.C.D., C.J.M.), Mayo Clinic, Rochester, Minn.

Correspondence to Jae Oh, Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. E-mail oh.jae{at}mayo.edu

Background— There are few data regarding medium-term outcome of coronary artery bypass grafting (CABG) in patients with severe left ventricular (LV) systolic dysfunction, particularly in the modern era, and even less assessing preoperative factors that might identify patients at highest risk.

Methods and Results— Three hundred seventy-nine consecutive patients with LV ejection fraction ≤35%, who underwent isolated first CABG between 1995 and 1999 were studied. Potential preoperative and perioperative predictors of outcome were recorded and patients followed-up for a median of 3.8 years. The primary study end-point was all-cause mortality. The 30-day, 1-year, and 3-year survival rates were 94.5%, 88%, and 81%, respectively. The independent predictors of mortality were preoperative estimated glomerular filtration rate (hazard ratio [HR], 0.98; 95% confidence interval [CI], 0.97 to 0.99 per mL/min/1.73m2; P<0.001) and age (HR, 1.03; 95% CI, 1.01 to 1.06 per year; P=0.005).

Conclusions— Patients with significant LV systolic dysfunction undergoing isolated CABG using contemporary techniques have a good medium-term survival. Renal dysfunction is the strongest independent predictor of mortality.


Key Words: coronary disease • kidney • surgery • survival